11beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients. (Q54591458)

1 June 2018

title

11beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients. (English)

1 reference

1 June 2018

0 references

0 references

1 reference

Raoul Desbriere

1

1 reference

1 June 2018

Vincent Vuaroqueaux

2

1 reference

1 June 2018

Vincent Achard

3

1 reference

1 June 2018

Sandrine Boullu-Ciocca

4

1 reference

1 June 2018

Martin Labuhn

5

1 reference

1 June 2018

Anne Dutour

6

1 reference

1 June 2018

Michel Grino

7

1 reference

1 June 2018

publication date

1 May 2006

1 reference

1 June 2018

published in

Obesity

1 reference

1 June 2018

volume

14

1 reference

1 June 2018

issue

5

1 reference

1 June 2018

page(s)

794-798

1 reference

1 June 2018

11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.92

A transgenic model of visceral obesity and the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.92

Postnatal diet-induced obesity in rats upregulates systemic and adipose tissue glucocorticoid metabolism during development and in adulthood: its relationship with the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.92

Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.92

Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.92

Minireview: hexose-6-phosphate dehydrogenase and redox control of 11{beta}-hydroxysteroid dehydrogenase type 1 activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.92

Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.92

The contribution of visceral adipose tissue to splanchnic cortisol production in healthy humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.92

Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11beta-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.92

Obesity and type 2 diabetes do not alter splanchnic cortisol production in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.92

Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.92

Chronic stress and obesity: a new view of "comfort food"

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.92

Steroid hormone receptors in human adipose tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.92

11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.92

31 March 2020

Identifiers

DOI

10.1038/OBY.2006.92

1 reference

1 June 2018

1 reference

1 June 2018